ES2118719T3 - METHOD FOR PREPARING LYSOZYME DIMERS. - Google Patents

METHOD FOR PREPARING LYSOZYME DIMERS.

Info

Publication number
ES2118719T3
ES2118719T3 ES90902033T ES90902033T ES2118719T3 ES 2118719 T3 ES2118719 T3 ES 2118719T3 ES 90902033 T ES90902033 T ES 90902033T ES 90902033 T ES90902033 T ES 90902033T ES 2118719 T3 ES2118719 T3 ES 2118719T3
Authority
ES
Spain
Prior art keywords
lisocima
lysocyme
lysocima
monomer
dimerization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902033T
Other languages
Spanish (es)
Inventor
Peter Herrmann
Peter Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nika Health Products Ltd
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Application granted granted Critical
Publication of ES2118719T3 publication Critical patent/ES2118719T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE FACILITA UN METODO PARA PREPARAR UN PRODUCTO DE DIMERO DE LISOCIMAALTAMENTE PURIFICADA QUE COMPRENDE DIMERIZACION DEL MONOMERO DE LISOCIMA CON UN REACTIVO DE ACOPLAMIENTO DE SUBERIMIDATO EN UNA SOLUCION TAMPON AJUSTADA A UN PH 10, DETENIENDO LA DIMERIZACION EN UN PUNTO DADO REDUCIENDO EL PH A 7 VIA LA ADICION DE HCI U OTRA SOLUCION ACIDA ADECUADA Y PURIFICANDO LA LISOCIMA DIMERICA MEDIANTE UNA SERIE DE PASOS DE ELUCION LLEVADOS A CABO UTILIZANDO CROMATOGRAFIA DE COLUMNA DE RESINA DE INTERCAMBIO DE IONES. LA LISOCIMA MONOMERICA QUE QUEDA NO DIMERIZADA MEDIANTE EL PRIMER PASO DE DIMERIZACION SE RECICLA EN EL PROCESO PARA INCREMENTAR EL RENDIMIENTO. EL PRESENTE SISTEMA ES VENTAJOSO EN TANTO EN CUANTO QUE SE PUEDEN PREPARAR GRANDES CANTIDADES DE DIMERO DE LISOCIMA PURIFICADA EFICAZMENTE Y DE FORMA RELATIVAMENTE BARATA, Y EL DIMERO DE LISOCIMA PRODUCIDO ASI ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES VIRALES Y/O BACTERIANAS SIN CAUSAR LOS EFECTOS CITOTOXICOS ASOCIADOS AL MONOMERO DE LISOCIMA.A METHOD IS PROVIDED FOR PREPARING A HIGHLY PURIFIED LYSOCIMA DIMER PRODUCT WHICH INCLUDES LISOCIMA MONOMER DIMERIZATION WITH A SUBERIMIDATE COUPLING REAGENT FITTED BY A 7 DAMINED A PIPE DIMENSION AT A 10 THE ADDITION OF HCI OR ANOTHER APPROPRIATE ACID SOLUTION AND PURIFYING THE DIMERIC LYSOCYME THROUGH A SERIES OF ELUTION STEPS CARRIED OUT USING ION EXCHANGE RESIN COLUMN CHROMATOGRAPHY. THE MONOMERIC LYSOCYME THAT IS NOT DIMERIZED BY THE FIRST DIMERIZATION STEP IS RECYCLED IN THE PROCESS TO INCREASE PERFORMANCE. THE PRESENT SYSTEM IS ADVANTAGEOUS IN SO FAR AS LARGE AMOUNTS OF EFFICIENTLY PURIFIED LYSOCIMA AND RELATIVELY CHEAP, CAN BE PREPARED, AND THE DYMER OF LISOCIMA CAUSED BY SALES AND OUR DISEASES IS SO USEFUL CYTOTOXICS ASSOCIATED WITH THE LISOCIMA MONOMER.

ES90902033T 1990-01-08 1990-01-08 METHOD FOR PREPARING LYSOZYME DIMERS. Expired - Lifetime ES2118719T3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US1990/000140 WO1991010731A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
CA002073351A CA2073351C (en) 1990-01-08 1990-01-08 Lysozyme dimers and method of preparing them
HU9202250A HU214509B (en) 1990-01-08 1990-01-08 Method of preparing of purified lysozyme dimers
RO92-0931A RO114805B1 (en) 1990-01-08 1990-01-08 Purified lyzozyme dimer and process for preparing the same
SG1996007945A SG49871A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
OA60242A OA09706A (en) 1990-01-08 1992-07-07 Method of preparing lysozyme dimers.

Publications (1)

Publication Number Publication Date
ES2118719T3 true ES2118719T3 (en) 1998-10-01

Family

ID=33136306

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902033T Expired - Lifetime ES2118719T3 (en) 1990-01-08 1990-01-08 METHOD FOR PREPARING LYSOZYME DIMERS.

Country Status (21)

Country Link
EP (1) EP0509984B1 (en)
JP (1) JP2732514B2 (en)
KR (1) KR0158216B1 (en)
AU (1) AU654651B2 (en)
BG (1) BG61040B1 (en)
BR (1) BR9007971A (en)
CA (1) CA2073351C (en)
DE (1) DE69032375T2 (en)
DK (1) DK0509984T3 (en)
ES (1) ES2118719T3 (en)
FI (1) FI101399B1 (en)
HK (1) HK1007456A1 (en)
HU (1) HU214509B (en)
LT (1) LT3422B (en)
LV (1) LV10119B (en)
MC (2) MC2242A1 (en)
NO (1) NO302484B1 (en)
OA (1) OA09706A (en)
RO (1) RO114805B1 (en)
SG (1) SG49871A1 (en)
WO (1) WO1991010731A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL173978B1 (en) * 1992-07-13 1998-05-29 Nika Health Products Ltd Method of obtaining a preparation capable to retard the synthesis of endogenous cytotoxic cytokinins
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (en) * 1995-01-13 2002-10-15 Nika Health Products Ltd New applications of a lysozyme dimer.
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
CA2851270C (en) * 2011-10-05 2023-03-14 The Rockefeller University Dimeric bacteriophage lysins
CN111751468A (en) * 2020-07-03 2020-10-09 上海艾魁英生物科技有限公司 Method for purifying lysozyme dimer and preparing standard substance thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850731B2 (en) 2006-10-04 2010-12-14 Seaspine, Inc. Articulating spinal implant

Also Published As

Publication number Publication date
KR0158216B1 (en) 1998-11-16
LTIP594A (en) 1994-12-27
NO302484B1 (en) 1998-03-09
AU4847490A (en) 1991-08-05
HK1007456A1 (en) 1999-04-09
DE69032375T2 (en) 1998-11-19
SG49871A1 (en) 1998-06-15
HUT65931A (en) 1994-07-28
MC2243A1 (en) 1993-02-23
FI101399B (en) 1998-06-15
WO1991010731A1 (en) 1991-07-25
CA2073351C (en) 2001-10-16
FI101399B1 (en) 1998-06-15
JPH05505092A (en) 1993-08-05
JP2732514B2 (en) 1998-03-30
BR9007971A (en) 1992-11-17
FI923123A0 (en) 1992-07-07
HU214509B (en) 1998-03-30
LV10119A (en) 1994-05-10
MC2242A1 (en) 1993-02-23
EP0509984B1 (en) 1998-06-03
LV10119B (en) 1995-02-20
HU9202250D0 (en) 1992-10-28
RO114805B1 (en) 1999-07-30
NO922626D0 (en) 1992-07-03
AU654651B2 (en) 1994-11-17
NO922626L (en) 1992-09-07
BG96578A (en) 1993-12-24
LT3422B (en) 1995-09-25
DE69032375D1 (en) 1998-07-09
BG61040B1 (en) 1996-09-30
EP0509984A1 (en) 1992-10-28
CA2073351A1 (en) 1991-07-09
OA09706A (en) 1993-08-30
FI923123A (en) 1992-07-07
DK0509984T3 (en) 1999-03-22

Similar Documents

Publication Publication Date Title
IE810433L (en) A specific cleavage linker
ES2118719T3 (en) METHOD FOR PREPARING LYSOZYME DIMERS.
BR9104494A (en) PROCESS FOR THE SEPARATION OF WEAK ORGANIC ACIDS OF LOW MOLECULAR WEIGHT, OF A LIQUID MIXTURE THAT CONTAINS THEM, AND WEAK BASED ANIONIC EXCHANGE RESIN AND TYPE GEL
BR9713920A (en) Process for the preparation and production of vinyl acetate
ES2122724T3 (en) PROCEDURE FOR THE SEPARATION BY RECTIFICATION OF (MET) ACRYLIC ACID FROM A MIXTURE CONTAINING (MET) ACRYLIC ACID.
GB1268869A (en) PROCESS FOR THE PREPARATION OF epsilon-CAPROLACTAM
ES8205741A1 (en) Process for the continuous production of sec. butanol.
EP0212688A3 (en) Substituted and crosslinked glucans, process for preparing them and use thereof
GB1290036A (en)
NO177531C (en) Process for the preparation of 1- (aminomethyl) cyclohexanacetic acid, as well as an intermediate for use in this process
KR870003056A (en) Basic amino acid separation method
JPS57185241A (en) Separating and purifying method of amino acid
GB1443106A (en) Process for producing tertiary butyl alcohol
SE8000742L (en) SET TO SYNTHETIZE SEC-BUTANOL OF LINEAR BUTENES
ATE37023T1 (en) PROCESS FOR PRODUCTION OF AETHYLTRIFLUORACETOACETATE.
YUMOTO et al. Comparison of tryptic peptides from the heavy and light subunits of calpain I and calpain II by high performance liquid chromatography
ATE74587T1 (en) PRODUCTION PROCESSES OF ESTERS OF HEXENDIC ACID.
DK473381A (en) Cationic adsorbent, and its method of preparation and application thereof
GEP19971033B (en) Method of preparing lysozyme dimers
Yankeelov Jr et al. Methylmaleic anhydride as a reversible blocking agent during specific arginine modification
FR2422613A1 (en) PROCESS FOR THE SEPARATION AND RECOVERY OF ISOBUTENE
DE69212072T2 (en) Continuous process for the production of sucrose 6 esters
JPS52131508A (en) Continuous preparation of diisopropylether
IL73370A0 (en) Process for the preparation of 2,4-dihydroxybenzophenones
NO922625D0 (en) PROCEDURE FOR THE PREPARATION OF RIBONUCLEASE DIMERS

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19920930

FG2A Definitive protection

Ref document number: 509984

Country of ref document: ES